StockData

NanoViricides, Inc. (NNVC) stock

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.16−0.08 (-6.45%)

Close on Nov 17, 2026Market cap $29.61MP/E –Yield –

NanoViricides total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

NanoViricides's total debt was $1.50M at Sep 30, 2023. For fiscal 2016 it was $5.47M. The highest annual figure on record is $5.47M in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2016Jun 30, 2016$5.47M–
FY2015Jun 30, 2015$0-100.0%
FY2014Jun 30, 2014$5.00M–
FY2013Jun 30, 2013$0–
FY2012Jun 30, 2012$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2024CQ3 2023Sep 30, 2023$1.50M-73.6%
Q3 FY2018CQ1 2018Mar 31, 2018$4.73M–
Q3 FY2017CQ1 2017Mar 31, 2017$0–
Q2 FY2017CQ4 2016Dec 31, 2016$5.91M–
Q1 FY2017CQ3 2016Sep 30, 2016$5.69M–

More NanoViricides figures

See a number that looks wrong?